Letter/Comment
AHA Comments on Drug Pricing Bill Under Consideration in the House
The AHA today submitted comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
Key Resources
Related Resources
Letter/Comment
Infographics
AHA Center for Health Innovation Market Scan